A private placement of common stock and warrants involving Hong Kong-based investment group Ally Bridge LB Healthcare Master Fund could pull in $2.2 million for Biocept. Strategic options are also being discussed by the company and Ally Bridge's Chinese affiliate for leveraging the liquid biopsy platform of Biocept in China.
Private placement could bring in $2.2M for Biocept
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.